[1] 张卫华, 唐萍, 周赤燕. NIPT检测技术在血清学筛查结果为高风险的非高龄孕妇中的应用[J]. 中国优生与遗传杂志, 2018, 26(9): 48-50.
[2] Taylor-Phillips S, Freeman K, Geppert J, et al.Accuracy of non-invasive prenatal testing using cell-free DNA for detection of Down,Edwards and Patau syndromes:a systematic review and meta-analysis[J]. BMJ Open, 2016, 6(1): 1-12.
[3] Zheng Y, Wan S, Dang Y, et al.Non-invasive prenatal testing for detection of trisomy 13,18,21 and sex chromosome aneuploidies in 8594 cases[J]. Ginekol Pol, 2019, 90(5): 270–273.
[4] Lu W, Huang T, Wang XR, et al. Next-generation sequencing: a follow-up of 36,913 singleton pregnancies with noninvasive prenatal testing in central China[J]. J Assist Reprod Genet, 2020, 37(12): 3143-3150.
[5] 姜楠, 张印帅, 宋丽杰, 等. 高通量测序技术在胎儿染色体拷贝数变异检测中的应用[J]. 中华医学遗传学杂志, 2020, 37(7): 779-784.
[6] Dai R, Yu Y, Zhang H, et al. Analysis of 17,428 pregnant women undergoing non-invasive prenatal testing for fetal chromosome in Northeast China[J]. Medicine, 2021, 100(6): 1-6.
[7] Bianchi DW. Turner syndrome: New insights from prenatal genomics and transcriptomics[J]. Am J Med Genet C Semin Med Genet, 2019, 181C(1): 29-33.
[8] ACOG.Cell-free DNA screening for fetal aneuploidy[J]. Obstet Gynecol, 2015, 126(3): e31-e37.
[9] Lo YM, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum[J]. Lancet, 1997, 350(9076): 485-487.
[10] Grati FR, Barlocco A, Grimi B, et al. Chromosome abnormalities investigated by non-invasive prenatal testing account for approximately 50 % of fetal unbalances associated with relevant clinical phenotypes[J]. Am J Med Genet A, 2010, 152A(6): 1434-1442.
[11] 王杰, 郭志远, 冀云鹏, 等. 母体X染色体异常对无创产前DNA性染色体非整倍检测结果的影响分析[J]. 中国生育健康杂志, 2018, 29(6): 533-535.
[12] 袁珮, 张玢, 刘建兵, 等. 母体性染色体异常对无创产前检测胎儿性染色体非整倍性的影响[J]. 中华医学遗传学杂志, 2020, 37(6): 617-620.
[13] Vandenberghe P, Wlodarska I, Tousseyn T, et al. Non-invasive detection of genomic imbalances in Hodgkin/Reed-Sternberg cells in early and advanced stage Hodgkin's lymphoma by sequencing of circulating cell-free DNA: a technical proof-of-principle study[J]. Lancet Haematol, 2015, 2(2): e55-65.
[14] Brady P, Brison N, Van Den Bogaert K, et al. Clinical implementation of NIPT-technical and biological challenges[J]. Clin Genet, 2016, 89(5): 523-530.
[15] Grömminger S, Yagmur E, Erkan S, et al. Fetal aneuploidy detection by cell-free DNA sequencing for multiple pregnancies and quality issues with vanishing twins[J]. J Clin Med, 2014, 3(3): 679-692.
[16] Bowden W, Skorupski J, Kovanci E, et al. Detection of novel copy number variants in uterine leiomyomas using high-resolution SNP arrays[J]. Mol Hum Reprod, 2009, 15(9): 563-568.
[17] Bianchi DW. Cherchez la femme:maternal incidental findings can explain discordant prenatal cell-free DNA sequencing results[J]. Genet Med, 2018, 20(9): 910-917.
[18] Bianchi DW,Chudova D,Sehnert AJ,et al.Noninvasive prenatal testing and incidental detection of occult maternal malignancies[J]. JAMA, 2015, 314(2):162-169.
[19] Ji X, Chen F, Zhou Y, et al. Copy number variation profile in noninvasive prenatal testing(NIPT) can identify co-existing maternal malignancies: Case reports and a literature review[J]. Taiwan J Obstet Gynecol, 2018, 57(6): 871-877.
[20] Suzumori N, Sekizawa A, Takeda E, et al. Retrospective details of false-positive and false-negative results in non-invasive prenatal testing for fetal trisomies 21, 18 and 13[J]. Eur J Obstet Gynecol Reprod Biol, 2021, 256: 75-81.
[21] 于婷, 李朔, 赵炜, 等. 双胎之一消亡导致非侵入性产前检测假阳性病例研究[J]. 中华医学遗传学杂志, 2019, 36(4): 327-330.
[22] Niles KM, Murji A, Chitayat D. Prolonged duration of persistent cell-free fetal DNA from vanishing twin[J]. Ultrasound Obstet Gynecol, 2018, 52(4): 547-548.
[23] He Y, Wang Y, Li Z, et al. Clinical performance of non-invasive prenatal testing for trisomies 21, 18 and 13 in twin pregnancies: A cohort study and a systematic meta-analysis[J]. Acta Obstet Gynecol Scand, 2020, 99(6): 731-743.
[24] Gil MM, Accurti V, Santacruz B, et al. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis[J]. Ultrasound Obstet Gynecol, 2017, 50(3): 302-314.
[25] Grati FR, Malvestiti F, Ferreira JC, et al. Fetoplacental mosaicism:potential implications for false-positive and false-negative noninvasive prenatal screening results[J]. Genet Med, 2014, 16(4): 620-624.
[26] Hall AL, Drendel HM, Verbrugge JL, et al. Positive cell-free fetal DNA testing for trisomy 13 reveals confined placental mosaicism[J]. Genet Med, 2013, 15(9): 729-732.
[27] Cho SY, Ki CS, Sohn YB, et al. The proportion of uniparental disomy is increased in Prader–Willi syndrome due to an advanced maternal childbearing age in Korea[J]. J Hum Genet, 2013, 58(3): 150-154.
[28] 谢润桂, 娄季武, 何怡. 3例NIPT三体高风险出现单亲二倍体病例的分析[J].中国优生与遗传杂志, 2020, 28(4): 403-407.
[29] 李辉. 中国不同出生胎龄新生儿出生体重,身长和头围的生长参照标准及曲线[J]. 中华儿科杂志, 2020(9): 738-746.
[30] Grömminger S, Erkan S, Schöck U, et al. The influence of low molecular weight heparin medication on plasma DNA in pregnant women[J]. Prenat Diagn, 2015, 35(11): 1155-1157.
